Page last updated: 2024-12-08
prorenone
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
prorenone: RN given refers to (6 beta,7 beta,17 beta)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 170819 |
| MeSH ID | M0066878 |
Synonyms (14)
| Synonym |
|---|
| prorenone |
| unii-y7bz8zy6tj |
| 3-(17beta-hydroxy-6beta,7beta-methylene-3-oxo-4-androsten-17alpha-yl)propionic acid gamma-lactone |
| y7bz8zy6tj , |
| 49848-04-6 |
| 3'h-cyclopropa(6,7)pregna-4,6-diene-21-carboxylic acid, 6,7-dihydro-17-hydroxy-3-oxo-, gamma-lactone, (6beta,7beta,17alpha)- |
| SC-24441 , |
| RRHHMFQGHCFGMH-LAPLKBAYSA-N |
| Q15708274 |
| 5a,7a-dimethyl-1,1a,4,5,5a,5b,6,7,7a,9,10,10a,10b,10c-tetradecahydro-3h-spiro[cyclopenta[a]cyclopropa[l]phenanthrene-8,2'-oxolane]-3,5'-dione |
| DTXSID50964446 |
| (1'r,2's,4's,5r,10'r,11's,14's,18's)-10',14'-dimethylspiro[oxolane-5,15'-pentacyclo[9.7.0.02,4.05,10.014,18]octadec-5-ene]-2,7'-dione |
| 6beta,7beta-dihydro-17-hydroxy-3-oxo-3'h-cyclopropa[6,7]-17alpha-pregna-4,6-diene-21-carboxylic acid gamma-lactone |
| 3'h-cyclopropa[6,7]pregna-4,6-diene-21-carboxylic acid, 6,7-dihydro-17-hydroxy-3-oxo-, gamma-lactone, (6beta,7beta,17alpha)- |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (9)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 9 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.15
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.15) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (11.11%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (88.89%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||